Roquefort Investments PLC (ROQ) - Total Assets
Based on the latest financial reports, Roquefort Investments PLC (ROQ) holds total assets worth GBX5.66 Million GBX (≈ $688.91 USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check ROQ capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Roquefort Investments PLC - Total Assets Trend (2021–2024)
This chart illustrates how Roquefort Investments PLC's total assets have evolved over time, based on quarterly financial data. Check Roquefort Investments PLC tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Roquefort Investments PLC - Asset Composition Analysis
Current Asset Composition (December 2024)
Roquefort Investments PLC's total assets of GBX5.66 Million consist of 6.3% current assets and 93.7% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 5.9% |
| Accounts Receivable | GBX25.38K | 0.4% |
| Inventory | GBX0.00 | 0.0% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX5.06 Million | 88.0% |
| Goodwill | GBX281.91K | 4.9% |
Asset Composition Trend (2021–2024)
This chart illustrates how Roquefort Investments PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Roquefort Investments PLC (ROQ) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Roquefort Investments PLC's current assets represent 6.3% of total assets in 2024, a decrease from 67.5% in 2021.
- Cash Position: Cash and equivalents constituted 5.9% of total assets in 2024, down from 19.7% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 92.0% of total assets, an increase from 32.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 88.0% of total assets.
Roquefort Investments PLC Competitors by Total Assets
Key competitors of Roquefort Investments PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
CSL Ltd
AU:CSL
|
Australia | AU$39.54 Billion |
|
BB Biotech AG
SW:BION
|
Switzerland | CHF2.64 Billion |
|
Concord Biotech Limited
NSE:CONCORDBIO
|
India | Rs20.23 Billion |
|
Pharming Group NV
AS:PHARM
|
Netherlands | €473.79 Million |
|
Innovita Biological Technology Co. Ltd. A
SHG:688253
|
China | CN¥2.23 Billion |
|
Wuhan Keqian Biology Co Ltd
SHG:688526
|
China | CN¥4.75 Billion |
|
Clarity Pharmaceuticals Ltd
AU:CU6
|
Australia | AU$255.67 Million |
|
OPTHEA LTD (SP.ADR/8)
F:UKJ2
|
Germany | €145.77 Million |
Roquefort Investments PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.80 | 0.79 | 62.36 |
| Quick Ratio | 2.80 | 0.79 | 62.36 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX1.13 Million | GBX-179.73K | GBX879.36K |
Roquefort Investments PLC - Advanced Valuation Insights
This section examines the relationship between Roquefort Investments PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.34 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -5.5% |
| Total Assets | GBX5.75 Million |
| Market Capitalization | $184.27K USD |
Valuation Analysis
Below Book Valuation: The market values Roquefort Investments PLC's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Roquefort Investments PLC's assets decreased by 5.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Roquefort Investments PLC (2021–2024)
The table below shows the annual total assets of Roquefort Investments PLC from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | GBX5.75 Million ≈ $699.70 |
-5.55% |
| 2023-12-31 | GBX6.09 Million ≈ $740.80 |
-21.62% |
| 2022-12-31 | GBX7.77 Million ≈ $945.17 |
+70.35% |
| 2021-12-31 | GBX4.56 Million ≈ $554.82 |
-- |
About Roquefort Investments PLC
Roquefort Therapeutics plc, a material biotech company, engages in the development of medicines for the treatment of cancer. Its product portfolio consists of five novel patent-protected pre-clinical anti-cancer medicines, which include Midkine antibodies with significance in vivo efficacy and toxicology studies, as well as orphan drug indication; Midkine RNA oligonucleotide therapeutics with nov… Read more